Gene · 5641
Papers1,807
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 1,807
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ferroptosis as a novel form of regulated cell death: Implications in the pathogenesis, oncometabolism and treatment of human cancer. | Genes Dis | 2022 | 35224151 | PubTator, text mining | PubMed |
| Role of Serine Proteases at the Tumor-Stroma Interface. | Front Immunol | 2022 | 35222418 | PubTator, text mining | PubMed |
| Lysosomes and lysosome-related organelles in immune responses. | FEBS Open Bio | 2022 | 35220694 | PubTator, text mining | PubMed |
| Asparaginyl endopeptidase protects against podocyte injury in diabetic nephropathy through cleaving cofilin-1. | Cell Death Dis | 2022 | 35217650 | PubTator, text mining | PubMed |
| Natural Products as Novel Neuroprotective Agents; Computational Predictions of the Molecular Targets, ADME Properties, and Safety Profile. | Plants (Basel) | 2022 | 35214883 | PubTator, text mining | PubMed |
| Single-Cell Sequencing Reveals an Intrinsic Heterogeneity of the Preovulatory Follicular Microenvironment. | Biomolecules | 2022 | 35204732 | PubTator, text mining | PubMed |
| The High Expression of Legumain in Canine Neoplasms: A Retrospective Analysis of 100 Cases. | Animals (Basel) | 2022 | 35203212 | PubTator, text mining | PubMed |
| Low-level lysosomal membrane permeabilization for limited release and sublethal functions of cathepsin proteases in the cytosol and nucleus. | FEBS Open Bio | 2022 | 35203107 | PubTator, text mining | PubMed |
| Mechanisms of Vitamin C Regulating Immune and Inflammation Associated with Neonatal Hypoxic-Ischemic Encephalopathy Based on Network Pharmacology and Molecular Simulation Technology. | Evid Based Complement Alternat Med | 2022 | 35198034 | PubTator, text mining | PubMed |
| Loss of legumain induces premature senescence and mediates aging-related renal fibrosis. | Aging Cell | 2022 | 35195326 | PubTator, text mining | PubMed |
| Supramolecular Nanomedicines of In-Situ Self-Assembling Peptides. | Front Chem | 2022 | 35186883 | PubTator, text mining | PubMed |
| Tumor-Derived Exosomes in Tumor-Induced Immune Suppression. | Int J Mol Sci | 2022 | 35163380 | PubTator, text mining | PubMed |
| Combined legumain- and integrin-targeted nanobubbles for molecular ultrasound imaging of breast cancer. | Nanomedicine | 2022 | 35150904 | PubTator, text mining | PubMed |
| Expression of extracellular matrix proteins nidogen-1 and legumain in endometrial carcinomas. | J Obstet Gynaecol Res | 2022 | 35128760 | PubTator, text mining | PubMed |
| Mice expressing fluorescent PAR2 reveal that endocytosis mediates colonic inflammation and pain. | Proc Natl Acad Sci U S A | 2022 | 35110404 | PubTator, text mining | PubMed |
| Attenuation of SARS-CoV-2 infection by losartan in human kidney organoids. | iScience | 2022 | 35106453 | PubTator, text mining | PubMed |
| Legumain Is an Endogenous Modulator of Integrin αvβ3 Triggering Vascular Degeneration, Dissection, and Rupture. | Circulation | 2022 | 35100526 | PubTator, text mining | PubMed |
| Transcriptomic and metabolomic associations with exposures to air pollutants among young adults with childhood asthma history. | Environ Pollut | 2022 | 35091019 | PubTator, text mining | PubMed |
| USP17 is required for peripheral trafficking of lysosomes. | EMBO Rep | 2022 | 35080333 | PubTator, text mining | PubMed |
| Comparison between Heat-Clearing Medicine and Antirheumatic Medicine in Treatment of Gastric Cancer Based on Network Pharmacology, Molecular Docking, and Tumor Immune Infiltration Analysis. | Evid Based Complement Alternat Med | 2022 | 35069767 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5641/papers?page=29